top of page

البريد الإلكتروني: bd@sidmexinovia.com

رقم الهاتف: +918866862020

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

الرئيسية >

Nirmacom Combipack

Nirmacom Combipack

Manufacturer/Marketed By : Hetero Healthcare Ltd

$55.53 $51.00

Nirmacom Combipack Tablet is an innovative pharmaceutical formulation that combines two potent antiretroviral agents, nirmatrelvir and ritonavir, designed to effectively manage mild to moderate symptoms of COVID-19 in adults at...

Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.

Nirmatrelvir 150mg + Ritonavir 100mg

Active Pharmaceutical Ingredient

Nirmacom Combipack

SKU Hetero Healthcare Ltd
السعر الأصلي

‏55.53 US$

سعر البيع

‏51.00 US$

Nirmacom Combipack Tablet is an innovative pharmaceutical formulation that combines two potent antiretroviral agents, nirmatrelvir and ritonavir, designed to effectively manage mild to moderate symptoms of COVID-19 in adults at risk of progressing to severe disease. This medication works by targeting the SARS-CoV-2 virus, which is responsible for the highly contagious respiratory illness known as COVID-19, thereby helping to reduce viral replication and improve recovery outcomes. It is crucial for patients to consult with a healthcare professional before starting Nirmacom, as it may not be suitable for everyone, especially those with certain underlying health conditions or who are taking other medications that could interact adversely. By offering a targeted approach to treating COVID-19, Nirmacom Combipack plays a vital role in the ongoing fight against this global pandemic. Patients should be aware of potential side effects and adhere strictly to prescribed dosages to maximize the benefits of this treatment. As COVID-19 continues to pose significant health risks, effective therapies like Nirmacom can be essential in managing symptoms and preventing the progression of the disease. Always seek advice from a healthcare provider to ensure this treatment aligns with your specific health needs and circumstances.

Active Pharmaceutical Ingredient

Nirmatrelvir 150mg + Ritonavir 100mg

الاستخدامات

• Nirmacom is utilized for the treatment of mild to moderate COVID-19 infections in adults. This combination of Nirmatrelvir and Ritonavir works effectively to inhibit viral replication. Patients diagnosed with COVID-19 can benefit from Nirmacom, especially when treatment is initiated early in the course of the illness. By targeting the virus, Nirmacom helps to reduce the severity of symptoms and prevent progression to more severe disease.
• In clinical settings, Nirmacom is prescribed for patients who are at risk of developing severe COVID-19 complications. By addressing the infection promptly, Nirmacom aids in managing symptoms and supporting recovery. It is particularly beneficial for adults who may have underlying health conditions that could exacerbate their COVID-19 infection. The timely use of Nirmacom can make a significant difference in patient outcomes.
• Nirmacom is also indicated for individuals who have tested positive for COVID-19 and exhibit mild to moderate symptoms. This medicine is designed to be taken soon after symptom onset, maximizing its efficacy. Healthcare providers recommend Nirmacom to help mitigate the viral load and alleviate discomfort associated with the infection. With its targeted action, Nirmacom can play a crucial role in the overall management of COVID-19 in adults.
• Additionally, Nirmacom is an important treatment option in the evolving landscape of COVID-19 management. It is used in outpatient settings, allowing patients to recover at home while receiving effective antiviral therapy. The use of Nirmacom is guided by clinical protocols to ensure that it is administered to those who need it most. This approach not only supports individual health but also contributes to public health efforts in controlling the spread of the virus.

فوائد

Nirmacom Combipack is an antiviral medication that is effective in treating mild to moderate COVID-19 infections in adults who are at high risk of developing severe illness. In patients with mild to moderate COVID-19 infections, this Nirmacom Combipack may help lower hospitalisation and mortality rates. This Nirmatrelvir 150mg + Ritonavir 100mg Tablets helps COVID-19 patients heal faster, allowing them to resume their daily activities sooner. Nirmacom Tablets contains nirmatrelvir and ritonavir as active ingredients, which work by blocking the protease enzyme of the virus, which can prevent it from spreading throughout the body.

تأثيرات جانبية

Nirmacom Combipack may cause some side effects. If you experience any side effects, contact your doctor immediately. Your doctor may give advice on how to control or lessen the severity of the side effects.

الآثار الجانبية الأكثر شيوعًا

• Diarrhoea
• Nausea
• Dizziness
• Headache

الآثار الجانبية الشائعة

• Rash
• Itching
• Muscle pain

كيفية الاستخدام

Take Nirmacom Combipack by mouth with a full glass of water, with or without food. Take this medicine exactly as prescribed by your doctor. Do not take more than the recommended dose or for a longer period of time. Do not break, crush or chew the tablets. If you miss a dose of Nirmatrelvir 150mg + Ritonavir 100mg Tablets, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and return to your regular dosing schedule. Do not take two doses at the same time to make up for a missed dose.

نصائح السلامة

• Alcohol: There no data available on the interaction of alcohol with Nirmatrelvir 150mg + Ritonavir 100mg Tablets. It is generally recommended to avoid consuming alcohol when taking any medication, including antiviral drugs, as alcohol can interfere with the drug's effectiveness and increase the risk of side effects.
• Kidney: Nirmacom Combipack should be used with caution in patients with kidney problems. It is important that patients with kidney disease closely monitor kidney function while taking this capsule. As there is limited information available consult your doctor before taking this medicine.
• Breastfeeding: Nirmacom Pack is not recommended for breastfeeding women. If you are breastfeeding, inform your doctor before taking this capsule.
• Liver: Nirmacom Tablets should be used with caution in patients with liver problems. It is important that patients with liver disease closely monitor liver function while taking this capsule. As there is limited information available consult your doctor before taking this medicine.
• Pregnancy: Nirmacom Pack is not recommended during pregnancy. If you are pregnant or planning on becoming pregnant, you should use effective birth control while taking this medicine. Consult your doctor before taking this medicine during pregnancy.
• Driving: There is limited information on the effect of Nirmacom Tablets on driving ability. However, if you experience any effects after taking this medicine that may affect your ability to drive safely, it is advised to avoid driving.

تنصل

تسعى شركة Sidmex Inovia جاهدة لتوفير معلومات دقيقة وموثوقة؛ ومع ذلك، فإن جميع المحتويات الموجودة على هذا الموقع الإلكتروني، بما في ذلك أوصاف المنتجات ومكوناتها، هي لأغراض إعلامية فقط ولا ينبغي اعتبارها بديلاً عن المشورة الطبية المهنية أو التشخيص أو العلاج.

يُنصح المستخدمون باستشارة أخصائي رعاية صحية مؤهل قبل اتخاذ أي قرارات طبية. لا ينبغي استخدام المعلومات المقدمة للتشخيص الذاتي أو العلاج الذاتي.

جميع المنتجات المذكورة مخصصة حصراً لأغراض التعاملات التجارية بين الشركات والاستفسارات بالجملة. لا تشجع شركة سيدمكس إينوفيا الاستخدام المباشر من قبل المستهلكين، وتهدف إلى دعم العلاقة بين أخصائي الرعاية الصحية والمريض، لا استبدالها.

جميع أسماء المنتجات والعلامات التجارية والأسماء التجارية مملوكة لأصحابها، ولا يعني استخدامها أي انتماء أو تأييد. لا تتحمل شركة سيدمكس إينوفيا أي مسؤولية عن أي تبعات ناتجة عن استخدام المعلومات الواردة في هذا الموقع الإلكتروني.

bottom of page